Base
N2480412013-12-26New YorkClassification

The tariff classification of Ramipril Tablets, imported in dosage form, from India

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly

Summary

The tariff classification of Ramipril Tablets, imported in dosage form, from India

Ruling Text

N248041 December 26, 2013 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9120 Mr. James Bogue BluePoint Laboratories Eastgate Business Park Eastgate Road, Building 1 Little Island, Cork Ireland RE: The tariff classification of Ramipril Tablets, imported in dosage form, from India Dear Mr. Bogue: In your letter dated November 18, 2013, you requested a tariff classification ruling. The subject product, Ramipril Tablets in 1.25 mg, 2.5 mg, 5 mg and 10 mg, is a medicinal preparation containing Ramipril, an angiotensin-converting enzyme (ACE) inhibitor, as the active ingredient. It is indicated for the treatment of mild to severe hypertension and for the reduction of myocardial infarction, stroke, and death in patients with a high risk of cardiovascular occurrences. The applicable subheading for the Ramipril Tablets in dosage form will be 3004.90.9120, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments." The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033. Sincerely, Gwenn Klein Kirschner Acting Director National Commodity Specialist Division